ECL Stock - Ecolab Inc.
Unlock GoAI Insights for ECL
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $15.74B | $15.32B | $14.19B | $12.73B | $11.79B |
| Gross Profit | $6.84B | $6.18B | $5.42B | $5.22B | $4.90B |
| Gross Margin | 43.5% | 40.3% | 38.2% | 41.0% | 41.5% |
| Operating Income | $2.61B | $2.16B | $1.61B | $1.68B | $1.71B |
| Net Income | $2.11B | $1.37B | $1.09B | $1.13B | $-1,205,100,000 |
| Net Margin | 13.4% | 9.0% | 7.7% | 8.9% | -10.2% |
| EPS | $7.43 | $4.82 | $3.83 | $3.95 | $-4.20 |
Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences segments. The Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, pulp and paper, commercial laundry, petroleum, refining, and petrochemical industries. The Global Institutional & Specialty segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education, and retail industries. Its Global Healthcare & Life Sciences segment offers specialized cleaning and sanitizing products to the healthcare, personal care, and pharmaceutical industries, such as infection prevention and surgical solutions, and end-to-end cleaning and contamination control solutions under the Ecolab, Microtek, and Anios brand names. The company's Other segment offers pest elimination services to detect, eliminate, and prevent pests, such as rodents and insects in restaurants, food and beverage processors, educational and healthcare facilities, hotels, quick service restaurant and grocery operations, and other institutional and commercial customers. This segment also provides colloidal silica for binding and polishing applications in semiconductor, catalyst, and aerospace component manufacturing, as well as chemical industries; and products and services that manage wash process through custom designed programs, premium products, dispensing equipment, water and energy management, and reduction, as well as real time data management. It sells its products through field sales and corporate account personnel, distributors, and dealers. The company was founded in 1923 and is headquartered in Saint Paul, Minnesota.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| November 3rd 2025 | Evercore ISI | Upgrade | Outperform | $300 |
| October 14th 2025 | Erste Group | Initiation | Buy | - |
| August 26th 2025 | Raymond James | Resumed | Market Perform | - |
| July 30th 2025 | Robert W. Baird | Upgrade | Outperform | $300 |
| April 21st 2025 | Seaport Research Partners | Upgrade | Buy | $290 |
| April 16th 2025 | Wells Fargo | Downgrade | Equal Weight | $230 |
| March 24th 2025 | Redburn Atlantic | Downgrade | Neutral | $270 |
| January 28th 2025 | Morgan Stanley | Upgrade | Overweight | $280← $263 |
| December 17th 2024 | BMO Capital Markets | Upgrade | Outperform | $290← $279 |
| November 4th 2024 | UBS | Downgrade | Neutral | $276 |
| October 18th 2024 | Jefferies | Upgrade | Buy | $310← $235 |
| August 13th 2024 | Wells Fargo | Initiation | Overweight | $270 |
| July 31st 2024 | BofA Securities | Upgrade | Buy | $272← $251 |
| July 31st 2024 | Citigroup | Upgrade | Buy | $265← $267 |
| July 8th 2024 | Stifel | Upgrade | Buy | $283← $233 |
Earnings History & Surprises
ECLEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 27, 2026 | — | — | — | — |
Q1 2026 | Feb 10, 2026 | $2.06 | — | — | — |
Q4 2025 | Oct 28, 2025 | $2.07 | $2.07 | 0.0% | = MET |
Q3 2025 | Jul 29, 2025 | $1.90 | $1.89 | -0.5% | ✗ MISS |
Q2 2025 | Apr 29, 2025 | $1.50 | $1.50 | 0.0% | = MET |
Q1 2025 | Feb 11, 2025 | $1.81 | $1.81 | 0.0% | = MET |
Q4 2024 | Oct 29, 2024 | $1.82 | $1.83 | +0.5% | ✓ BEAT |
Q3 2024 | Jul 30, 2024 | $1.67 | $1.68 | +0.6% | ✓ BEAT |
Q2 2024 | Apr 30, 2024 | $1.34 | $1.34 | 0.0% | = MET |
Q1 2024 | Feb 13, 2024 | $1.54 | $1.55 | +0.6% | ✓ BEAT |
Q4 2023 | Oct 31, 2023 | $1.52 | $1.54 | +1.3% | ✓ BEAT |
Q3 2023 | Aug 1, 2023 | $1.21 | $1.24 | +2.5% | ✓ BEAT |
Q2 2023 | May 2, 2023 | $0.86 | $0.88 | +2.3% | ✓ BEAT |
Q1 2023 | Feb 14, 2023 | $1.25 | $1.27 | +1.6% | ✓ BEAT |
Q4 2022 | Nov 1, 2022 | $1.31 | $1.30 | -0.8% | ✗ MISS |
Q3 2022 | Jul 26, 2022 | $1.09 | $1.10 | +0.9% | ✓ BEAT |
Q2 2022 | Apr 26, 2022 | $0.82 | $0.82 | 0.0% | = MET |
Q1 2022 | Feb 15, 2022 | $1.31 | $1.28 | -2.3% | ✗ MISS |
Q4 2021 | Oct 26, 2021 | $1.30 | $1.41 | +8.5% | ✓ BEAT |
Q3 2021 | Jul 27, 2021 | $1.21 | $1.22 | +0.8% | ✓ BEAT |
Latest News
Citigroup Maintains Buy on Ecolab, Lowers Price Target to $315
➖ NeutralEcolab Raises Quarterly Cash Dividend From $0.65 To $0.73 Per Share
📈 PositiveEvercore ISI Group Upgrades Ecolab to Outperform, Raises Price Target to $300
📈 PositiveUBS Maintains Neutral on Ecolab, Lowers Price Target to $291
➖ NeutralEcolab shares are trading lower. Multiple firms have lowered their price targets on the stock.
📉 NegativeCitigroup Maintains Buy on Ecolab, Lowers Price Target to $323
📈 PositiveStifel Maintains Buy on Ecolab, Lowers Price Target to $300
➖ NeutralJP Morgan Maintains Neutral on Ecolab, Raises Price Target to $265
➖ NeutralBarclays Maintains Overweight on Ecolab, Raises Price Target to $300
📈 PositiveEcolab Life Sciences Launches Klercide Rapid Sporicide For Pharma Cleanrooms, Cuts Turnover Time, Residue And Costs
📈 PositiveEcolab shares are trading lower despite reporting better-than-expected Q3 financial results.
📉 NegativeCORRECTION: Ecolab Q3 Adj. EPS $2.07, Inline, Sales $4.165B Beat $4.120B Estimate
📈 PositiveEcolab Sees Q4 Adj EPS $2.02-$2.12 vs $2.08 Est
➖ NeutralEcolab Narrows FY2025 Adj EPS Guidance from $7.42-$7.62 to $7.48-$7.58 vs $7.53 Est
➖ NeutralEcolab Q3 Adj. EPS $2.05 Misses $2.07 Estimate, Sales $4.165B Beat $4.120B Estimate
➖ NeutralWells Fargo Maintains Equal-Weight on Ecolab, Raises Price Target to $270
📈 PositiveUBS Maintains Neutral on Ecolab, Raises Price Target to $299
➖ NeutralEcolab Unveils Ecolab CIP IQ, An AI-powered Clean-In-Place Solution For The Food And Beverage Industry
📈 PositiveBMO Capital Maintains Outperform on Ecolab, Raises Price Target to $310
📈 PositiveBaird Maintains Outperform on Ecolab, Raises Price Target to $306
📈 PositiveFrequently Asked Questions about ECL
What is ECL's current stock price?
What is the analyst price target for ECL?
What sector is Ecolab Inc. in?
What is ECL's market cap?
Does ECL pay dividends?
Similar Stocks
Basic Materials SectorExplore stocks similar to ECL for comparison